Research and Development at Genzyme

Innovative therapies for debilitating diseases

Since its founding in 1981, Genzyme has dedicated itself to discovering and developing innovative products and services to improve the lives of patients with debilitating diseases. This commitment has driven Genzyme to establish many new models in treatment and testing and has brought hope to thousands of people affected by devastating and, in many cases, previously untreatable illnesses.

Genzyme focuses its efforts on well-defined medical areas with serious, unmet needs—where breakthrough therapies and services might significantly improve patients’ lives. Genzyme’s research and development efforts span a range of medical areas, including genetic disease, kidney disease, orthopaedics, cardiovascular disease, cancer, immune-mediated disease and transplantation.

Genzyme’s research platforms include protein and antibody therapies, polymers and small molecule therapies, cell and gene therapies, and biomaterials. The company seeks to address debilitating medical problems by identifying and developing the best possible therapeutic intervention.

Continually working to identify new opportunities

For more than two decades, Genzyme has viewed external collaborations as a fundamental part of its business, and the company is always looking to evaluate exciting opportunities. Genzyme has partnered with universities, research institutions, and private companies to find, develop and commercialize products that improve the lives of patients around the world.

	Genzyme Technologies Learn more about the basic science that underscores our Research and Development and product history. More >		Medical Areas Learn more about Genzyme medical areas More >

Terms and Conditions of Use | Privacy Policy | © 2003-2010 Genzyme Corporation. All rights reserved.